Pfizer begins testing an omicron-specific COVID-19 vaccine

shutterstock_1989723350

Pfizer and BioNTech announced on Tuesday that they have begun a clinical trial to evaluate a new, omicron-specific vaccine for COVID-19. People who are vaccinated and boosted appear to be better protected against severe disease and hospitalization